Prof. Dr. Özge Gümüşay

Comparison of three different concurrent chemoradiation regimens for treatment of laryngeal cancer

European Archives of Oto-Rhino-Laryngology, 2015

DOI 10.1007/s00405-015-3854-8 PMID 26683470 4 Zitationen (Europe PMC) Quelle: OpenAlex

Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients

Wiener klinische Wochenschrift, 2015

DOI 10.1007/s00508-015-0858-8 PMID 26373751 2 Zitationen (Europe PMC) Quelle: OpenAlex

Factors predicting the development of distant metastases in patients with head and neck squamous cell carcinoma: A retrospective study from a single centre.

PubMed, 2015

PMID 26011345 4 Zitationen (Europe PMC) Quelle: OpenAlex

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.

Journal of Clinical Oncology, 2015

DOI 10.1200/jco.2015.33.3_suppl.25 Quelle: OpenAlex

Salvage Chemotherapy with Weekly Paclitaxel for Metastatic Melanoma

Asian Pacific Journal of Cancer Prevention, 2015

DOI 10.7314/apjcp.2015.16.6.2581 PMID 25824800 Frei zugänglicher VolltextQuelle: OpenAlex

Akciğerin Primer Şeffaf Hücreli Şeker Tümörü: Bir Olgu Sunumu

Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi, 2015

Quelle: OpenAlex

Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-d-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin

Annals of Nuclear Medicine, 2014

DOI 10.1007/s12149-014-0896-8 PMID 25270711 2 Zitationen (Europe PMC) Quelle: OpenAlex

Factors predicting recurrence in patients with grade III glial tumors: impact of adjuvant temozolomide on recurrence.

PubMed, 2014

PMID 25536613 Quelle: OpenAlex

Solitary Cerebral Metastases from Renal Cell Carcinoma 16 years After Nephrectomy

Acta Oncologica Turcica, 2014

DOI 10.5505/aot.2014.47966 Frei zugänglicher VolltextQuelle: OpenAlex

Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma

International Urology and Nephrology, 2013

DOI 10.1007/s11255-013-0613-x PMID 24307427 20 Zitationen (Europe PMC) Quelle: OpenAlex

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Breast Cancer, 2013

DOI 10.1007/s12282-013-0441-y PMID 23335064 20 Zitationen (Europe PMC) Quelle: OpenAlex

Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

Journal of Cancer Research and Clinical Oncology, 2013

DOI 10.1007/s00432-013-1553-7 PMID 24292400 14 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B

Hepatology Research, 2012

DOI 10.1111/j.1872-034x.2012.01057.x PMID 22734888 24 Zitationen (Europe PMC) Quelle: OpenAlex

Oral Etoposide for Platinum-Resistant and Recurrent Epithelial Ovarian Cancer: a Study by the Anatolian Society of Medical Oncology

Asian Pacific Journal of Cancer Prevention, 2012

DOI 10.7314/apjcp.2012.13.8.3973 PMID 23098502 19 Zitationen (Europe PMC) Quelle: OpenAlex

Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

Oncology, 2012

DOI 10.1159/000338782 PMID 22814315 21 Zitationen (Europe PMC) Quelle: OpenAlex

Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study.

Journal of Clinical Oncology, 2012

DOI 10.1200/jco.2012.30.15_suppl.638 1 Zitation (OpenAlex) Quelle: OpenAlex

Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer

Quelle: Profilseite auf acibadem.com.tr

Immunotherapy Toxicity: identification and management

Quelle: Profilseite auf acibadem.com.tr

Pembrolizumab for Early Triple-Negative Breast Cancer

Quelle: Profilseite auf acibadem.com.tr